Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Meningitis B Vaccine (2026)

UK Health Security Agency

This public procurement record has 3 releases in its history.

Award

30 Jun 2026 at 11:02

UK7 - Contract Details Notice
Award

22 May 2026 at 15:42

UK6 - Contract Award Notice
Award

09 Sep 2025 at 11:08

UK5 - Transparency Notice
Summary of the contracting process

The UK Health Security Agency (UKHSA), acting as the buyer on behalf of the Secretary of State for Health and Social Care, has engaged in a completed direct award procurement process for the "Meningitis B Vaccine (2026)" contract. The tender, awarded to GlaxoSmithKline UK Limited, focuses on providing vaccines for meningococcal B disease in the national childhood immunisation programme and a targeted programme for at-risk adults against Gonorrhoea. This procurement, under UK legal statute 2023/54, proceeded via a direct award due to exclusive rights held by the supplier. With key operations based out of London, the contract was signed on 10 June 2026 and covers the period from 1 October 2026 to 30 September 2029, with potential for a 12-month extension. The contract's direct award approach reflects the absence of reasonable alternatives due to intellectual property considerations.

This contract presents significant opportunities for large-scale pharmaceutical companies with expertise in vaccine development and supply, particularly those that hold exclusive rights or possess unique capabilities in meningococcal disease prevention. Businesses in the pharmaceutical industry, especially those engaged in vaccine production, can benefit from engaging in such governmental contracts, offering consistent demand and potential for contract extensions. Furthermore, this tender reinforces the established business relationship between UKHSA and GlaxoSmithKline, highlighting the reliance on suppliers with a robust supply chain and capacity to meet the strict standards and delivery schedules mandated by national health programmes. This contract continues to strengthen opportunities for suppliers capable of adapting to shifts in vaccine demand amid potential health crises.

How relevant is this notice?

Notice Information

Notice Title

Meningitis B Vaccine (2026)

Notice Description

The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. Value - The contract value is withheld from publication pursuant to regulation 94(2)(b) of the Procurement Act 2023, so as not to prejudice the legitimate commercial interest of the supplier.

Procurement Information

The following conditions are met in relation to the public contract under Schedule 5, Paragraph 5 (a, b) of the Procurement Act 2023- (a) due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-059678
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/061108-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£1
Contracts Value
£1

Notice Dates

Publication Date
30 Jun 20263 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
22 May 20264 months ago
Contract Period
1 Oct 2026 - 30 Sep 2029 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active, Pending
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK Health Security Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

GlaxoSmithKline UK Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...